Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2022-08-11 00:00:00 ET · period of report 2022-08-11 · accession 0001055726-22-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-11 | 2022-08-11 | INO | Weiner David B. | Dir | M - OptEx | $2.16 | +11.9K | 904.5K | +1% | +$25.6K |
| D | 2022-08-11 | 2022-08-11 | INO | Weiner David B. | Dir | S - Sale+OE | $2.66 | -11.9K | 892.6K | -1% | -$31.6K |
| D | 2022-08-11 | 2022-08-11 | INO | Weiner David B. | Dir | M - OptEx | $0.00 | -11.9K | 11.9K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-11 | M | A | 11,875 | $2.16 | 904,500 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-11 | S | D | 11,875 | $2.66 | 892,625 | D | — | — | (F2) These transactions were executed in multiple trades at prices ranging from $2.66 to $2.69, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 3 | Derivative | Common Stock Option | 2022-08-11 | M | D | 11,875 | $0.00 | 11,875 | D | $2.16 · 2013-03-14 to 2023-03-14 | 11,875 Common Stock | (F3) Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014. |